110 related articles for article (PubMed ID: 9746487)
1. Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide.
Ritchie RH; Schiebinger RJ; LaPointe MC; Marsh JD
Am J Physiol; 1998 Oct; 275(4):H1370-4. PubMed ID: 9746487
[TBL] [Abstract][Full Text] [Related]
2. Acute antihypertrophic actions of bradykinin in the rat heart: importance of cyclic GMP.
Rosenkranz AC; Hood SG; Woods RL; Dusting GJ; Ritchie RH
Hypertension; 2002 Oct; 40(4):498-503. PubMed ID: 12364353
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction limits the antihypertrophic action of bradykinin in rat cardiomyocytes.
Rosenkranz AC; Dusting GJ; Ritchie RH
J Mol Cell Cardiol; 2000 Jun; 32(6):1119-26. PubMed ID: 10888262
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin blocks angiotensin II-induced hypertrophy in the presence of endothelial cells.
Ritchie RH; Marsh JD; Lancaster WD; Diglio CA; Schiebinger RJ
Hypertension; 1998 Jan; 31(1):39-44. PubMed ID: 9449388
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycaemia abolishes the antihypertrophic efficacy of bradykinin in rat ventricular myocytes.
Rosenkranz AC; Dusting GJ; Ritchie RH
Clin Exp Pharmacol Physiol; 1999 Jul; 26(7):519-21. PubMed ID: 10405778
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Matoba S; Tatsumi T; Keira N; Kawahara A; Akashi K; Kobara M; Asayama J; Nakagawa M
Circulation; 1999 Feb; 99(6):817-22. PubMed ID: 9989969
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide prevents acute hypertrophic responses in the diabetic rat heart: importance of cyclic GMP.
Rosenkranz AC; Hood SG; Woods RL; Dusting GJ; Ritchie RH
Diabetes; 2003 Sep; 52(9):2389-95. PubMed ID: 12941780
[TBL] [Abstract][Full Text] [Related]
8. Activation of IP prostanoid receptors prevents cardiomyocyte hypertrophy via cAMP-dependent signaling.
Ritchie RH; Rosenkranz AC; Huynh LP; Stephenson T; Kaye DM; Dusting GJ
Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1179-85. PubMed ID: 15072955
[TBL] [Abstract][Full Text] [Related]
9. Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells.
Zhao Y; Biermann T; Luther C; Unger T; Culman J; Gohlke P
J Neurochem; 2003 May; 85(3):759-67. PubMed ID: 12694402
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
[TBL] [Abstract][Full Text] [Related]
11. Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes.
Ishigai Y; Mori T; Ikeda T; Fukuzawa A; Shibano T
Am J Physiol; 1997 Dec; 273(6):H2659-63. PubMed ID: 9435601
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors.
Dubey RK; Jackson EK; Lüscher TF
J Clin Invest; 1995 Jul; 96(1):141-9. PubMed ID: 7615784
[TBL] [Abstract][Full Text] [Related]
13. Role of endothelial nitric oxide in the response to angiotensin II of small mesenteric arteries of the rat.
Andriantsitohaina R; Okruhlicova L; Côrtes SF; Lagaud GJ; Randriamboavonjy V; Muller B; Stoclet JC
J Vasc Res; 1996; 33(5):386-94. PubMed ID: 8862144
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.
Belhassen L; Kelly RA; Smith TW; Balligand JL
J Clin Invest; 1996 Apr; 97(8):1908-15. PubMed ID: 8621775
[TBL] [Abstract][Full Text] [Related]
15. [The role of nitric oxide in the angiotensin II-induced hypertrophy of cardiac myocytes].
Zhan CD; Wang TH; Pan JY
Sheng Li Xue Bao; 1999 Dec; 51(6):660-6. PubMed ID: 11498936
[TBL] [Abstract][Full Text] [Related]
16. Astrocytes are responsive to endothelium-derived relaxing factor (EDRF).
Ishizaki Y; Ma LJ; Morita I; Murota S
Neurosci Lett; 1991 Apr; 125(1):29-30. PubMed ID: 1713318
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivo.
Alvarez A; Piqueras L; Blazquez MA; Sanz MJ
Br J Pharmacol; 2001 Jun; 133(4):485-94. PubMed ID: 11399665
[TBL] [Abstract][Full Text] [Related]
18. Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis.
Schuller-Petrovic S; Siedler S; Kern T; Meinhart J; Schmidt K; Brunner F
Br J Pharmacol; 1997 Oct; 122(4):772-8. PubMed ID: 9375976
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
[TBL] [Abstract][Full Text] [Related]
20. Endothelial vasodilator production by uterine and systemic arteries. I. Effects of ANG II on PGI2 and NO in pregnancy.
Magness RR; Rosenfeld CR; Hassan A; Shaul PW
Am J Physiol; 1996 Jun; 270(6 Pt 2):H1914-23. PubMed ID: 8764239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
